Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naloxegol for Prevention of Postoperative Ileus After Cystectomy
NCT04219046Phase 2Withdrawn
- Sponsor
- Institut Paoli-Calmettes
- Start
- Jan 2032
- Primary completion
- Jan 2032
- Modality
- Metabolically Activated Prodrugs
01
Overview
Phase 2, randomised, double-blind trial of naloxegol in postoperative ileus (POI), sponsored by Institut Paoli-Calmettes. Planned start Jan 2032; status: withdrawn.
02
Drugs
naloxegol
03
Conditions
postoperative ileus (POI)
Beyond the preview
Go deeper on NCT04219046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04219046.